In this retrospective cohort of patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement ...

JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device.

Corewell Health's Dr. Eanas Yassa performed a first-of-its-kind procedure in Michigan to treat a thoracoabdominal aortic ...

The ALIGN-AR 2-year Follow-Up data confirmed the continued safety and efficacy of the Trilogy heart valve system for patients with severe, symptomatic aortic regurgitation (AR) at high risk for ...